Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
248.50    -1.50 (-0.60%)
Bid:
245.00
Ask:
252.00
Spread: 7.00 (2.857%)
Market Cap: £225.74m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Director Share Dealing

28 Feb 2025 07:00

RNS Number : 7962Y
Concurrent Technologies PLC
28 February 2025
 

28 February 2025

Concurrent Technologies Plc

(the "Company" or the "Group")

Director Share Dealing

 

Concurrent Technologies PLC (AIM: CNC), a designer and manufacturer of leading-edge computer products, systems and mission critical solutions used in high-performance markets by some of the world's major OEMs, announces that Brent Salgat, Director & Chief Revenue Officer, has sold 40,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at an average price of 166.8p to cover associated tax liabilities from his exercise of 150,000 share options, as notified on 13th September 2024.

 

Following the sale of the Ordinary Shares, Mr Salgat has a total interest in 110,000 Ordinary Shares, representing 0.13 per cent of the Company's issued share capital.

 

Enquiries:

 

Concurrent Technologies Plc Miles Adcock - CEO

Kim Garrod - CFO

 

+44 (0)1206 752626

 

Alma Strategic Communications Josh Royston

Hannah Campbell

 

+44 (0)20 3405 0205

 

Cavendish Capital Markets Limited (NOMAD) Neil McDonald

Peter Lynch

 

+44 (0)131 220 9771

+44 (0)131 220 9772

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded Plug In Cards and Systems for use in a wide range of high performance, long life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.

For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Brent Salgat

2.

Reason for the Notification

a)

Position/status

Chief Revenue Officer & Executive Director

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Concurrent Technologies Plc

b)

LEI

213800422HXP2X6UPD94

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 pence each

Identification code

GB0002183191

b)

Nature of the Transaction

Exercise of Options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

167 pence

30,000 ordinary shares

US$2.10 (166.48 pence)

10,000 ordinary shares

d)

Aggregated information

Aggregated volume price

N/A - Single Transaction

e)

Date of the transaction

26 February 2025

f)

Place of the transaction

AIM, London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEAXAFFSEAA
Date   Source Headline
27th Dec 20137:00 amRNSTrading Update
13th Dec 20134:31 pmRNSProduct Launch
6th Dec 20131:35 pmRNSHolding(s) in Company
28th Nov 201311:31 amRNSHolding(s) in Company
1st Nov 20133:45 pmRNSTotal Voting Rights
24th Oct 20134:13 pmRNSProduct Launch
23rd Oct 20132:56 pmRNSTransaction in Own Shares
8th Oct 20132:35 pmRNSProduct Launch
4th Oct 20135:01 pmRNSTransaction in Own Shares
1st Oct 20133:13 pmRNSTotal Voting Rights
25th Sep 20132:38 pmRNSTransaction in Own Shares
4th Sep 20132:42 pmRNSTransaction in Own Shares
22nd Aug 20137:00 amRNSInterim Results
16th Aug 20133:58 pmRNSNotice of Results
12th Aug 201312:40 pmRNSTrading Update
21st Jun 201312:20 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSProduct Launch
28th May 20132:00 pmRNSAGM Statement
24th May 20133:10 pmRNSProduct Launch
13th May 20134:25 pmRNSProduct Launch
24th Apr 20135:01 pmRNSDistribution of Annual Report and Accounts
9th Apr 20137:00 amRNSFinal Results
19th Mar 20134:25 pmRNSNotice of Results & Dividend
1st Mar 20132:15 pmRNSProduct Launch
24th Dec 20127:00 amRNSTrading Update
21st Dec 20121:17 pmRNSProduct Launch
21st Nov 20123:27 pmRNSHolding(s) in Company
5th Nov 201212:25 pmRNSProduct Launch
31st Oct 201210:32 amRNSTotal Voting Rights
19th Sep 20125:28 pmRNSHolding(s) in Company
5th Sep 20127:00 amRNSInterim Results
29th Aug 20125:36 pmRNSNotice of Results
22nd Jun 20124:42 pmRNSTotal Voting Rights
14th Jun 20123:50 pmRNSTransaction in Own Shares
7th Jun 20127:00 amRNSProduct Launch
31st May 20123:30 pmRNSTotal Voting Rights
29th May 20121:30 pmRNSAGM Statement
22nd May 201212:21 pmRNSTreasury Shares
8th May 20127:00 amRNSDistribution of Annual Report and Accounts
4th May 20123:53 pmRNSHolding(s) in Company
17th Apr 20123:51 pmRNSHolding(s) in Company
12th Apr 201211:44 amRNSHolding(s) in Company
26th Mar 20127:00 amRNSPreliminary Results
16th Mar 20123:17 pmRNSNotice of Results
6th Mar 20121:45 pmRNSDividend Declaration
16th Jan 20127:00 amRNSProduct Launch
29th Dec 20115:46 pmRNSDirector/PDMR Shareholding
22nd Dec 201112:41 pmRNSTrading Statement
9th Dec 20114:53 pmRNSProduct Launch
2nd Dec 201111:03 amRNSProduct Launch

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.